Classic oncogenic drivers of pancreatic ductal adenocarcinoma have been shown to activate β1 integrin (ITGB1) signaling pathways to promote immune evasion and tumor progression, through PD-L1 upregulation [49]. The gene discussed is CD274; the disease is pancreatic ductal adenocarcinoma.